Valeo Pharma announces the closing of a share purchase agreement with Xediton Pharmaceuticals Inc. Canada NewsWire MONTREAL, Feb. 6, 2025...
Suspension de la négociation par l'Organisme canadien de réglementation des investissements - VPH Canada NewsWire TORONTO, le 2...
Canadian Investment Regulatory Organization Trading Halt - VPH Canada NewsWire TORONTO, Oct. 2, 2024 TORONTO, Oct. 2, 2024 /CNW/ - The following...
VALEO PHARMA ENTAME DES PROCÉDURES DE RESTRUCTURATION EN VERTU DE LA LACC AFIN DE METTRE EN ŒUVRE UN...
VALEO PHARMA INITIATES RESTRUCTURING PROCEEDINGS UNDER THE CCAA TO IMPLEMENT A REVIEW OF ITS STRATEGIC...
VALEO PHARMA REPORTS THIRD QUARTER 2024 REVENUES Canada NewsWire MONTREAL, Sept. 12, 2024 Q3-24 revenues of $12.6 million, down 11% from Q3-23...
VALEO PHARMA TO HOST THIRD QUARTER 2024 RESULTS CONFERENCE CALL / WEBCAST Canada NewsWire MONTREAL, Sept. 9, 2024 MONTREAL, Sept. 9, 2024 /CNW/...
VALEO PHARMA AMENDS CREDIT FACILITY WITH SAGARD HEALTHCARE ROYALTY PARTNERS, LP Canada NewsWire MONTREAL...
VALEO PHARMA ANNOUNCES VOLUNTARY DELISTING FROM OTCQB VENTURE MARKET Canada NewsWire MONTREAL, Aug. 29, 2024...
VALEO PHARMA ANNOUNCES LEADERSHIP CHANGES Canada NewsWire MONTREAL, Aug. 6, 2024 MONTREAL, Aug. 6, 2024 /CNW/...
VALEO PHARMA ANNOUNCES SENIOR EXECUTIVE APPOINTMENT AND BOARD OF DIRECTORS CHANGE Canada NewsWire MONTREAL...
VALEO PHARMA REPORTS RECORD SECOND QUARTER 2024 REVENUES Canada NewsWire MONTREAL, June 13, 2024 Record Q2-24...
VALEO PHARMA ANNOUNCES RESTRUCTURING OF COMMERCIAL FIELD OPERATIONS TO SUPPORT PATH TO PROFITABILITY Canada...
VALEO PHARMA TO HOST SECOND QUARTER 2024 RESULTS CONFERENCE CALL / WEBCAST Canada NewsWire MONTREAL, June 4...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Subscribe to Ad free and enjoy an ad-free experience
Try Now
Keep the Ads